speb/financial-data huggingface dataset:
CLRB cash_flow (annual, 2025-12-31) — Purchase Of PPE: -5880.00
CLRB cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -5880.00
CLRB income_statement (annual, 2025-12-31) — Reconciled Depreciation: 213597.00
CLRB income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 49461.00
CLRB income_statement (annual, 2025-12-31) — Research And Development: 11498761.00
CLRB income_statement (quarterly, 2025-12-31) — Research And Development: 3158561.00
CLRB balance_sheet (annual, 2025-12-31) — Retained Earnings: -269133500.00
CLRB balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -269133500.00
CLRB income_statement (annual, 2025-12-31) — Selling General And Administration: 11481083.00
CLRB income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2532068.00
CLRB balance_sheet (annual, 2025-12-31) — Share Issued: 4240129.00
CLRB balance_sheet (quarterly, 2025-12-31) — Share Issued: 4240129.00
CLRB cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2263704.00
CLRB cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 567788.00
CLRB balance_sheet (annual, 2025-12-31) — Stockholders Equity: 8537164.00
CLRB balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 8537164.00
CLRB balance_sheet (annual, 2025-12-31) — Tangible Book Value: 8016386.00
CLRB balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 8016386.00
CLRB income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLRB income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLRB income_statement (annual, 2025-12-31) — Tax Provision: 0.00
CLRB income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CLRB income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CLRB balance_sheet (annual, 2025-12-31) — Total Assets: 14978321.00
CLRB balance_sheet (quarterly, 2025-12-31) — Total Assets: 14978321.00
CLRB balance_sheet (annual, 2025-12-31) — Total Capitalization: 8537164.00
CLRB balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 8537164.00
CLRB balance_sheet (annual, 2025-12-31) — Total Debt: 409586.00
CLRB balance_sheet (quarterly, 2025-12-31) — Total Debt: 409586.00
CLRB balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 8537164.00
CLRB balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 8537164.00
CLRB income_statement (annual, 2025-12-31) — Total Expenses: 22979844.00
CLRB income_statement (quarterly, 2025-12-31) — Total Expenses: 5690629.00
CLRB balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 6441157.00
CLRB balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 6441157.00
CLRB balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 939451.00
CLRB balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 939451.00
CLRB balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1691420.00
CLRB balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1691420.00
CLRB income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -22979844.00
CLRB income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -5690629.00
CLRB income_statement (annual, 2025-12-31) — Total Unusual Items: 753707.00
CLRB income_statement (quarterly, 2025-12-31) — Total Unusual Items: 297833.00
CLRB income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 753707.00
CLRB income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 297833.00
CLRB balance_sheet (annual, 2025-12-31) — Working Capital: 9288728.00
CLRB balance_sheet (quarterly, 2025-12-31) — Working Capital: 9288728.00
CLRB income_statement (quarterly, 2026-03-31) — +Operating Expense: 5793942.00
CLRB income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
CLRB balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 277601713.00
CLRB income_statement (quarterly, 2026-03-31) — Basic Average Shares: 4240129.00
CLRB income_statement (quarterly, 2026-03-31) — Basic EPS: -1.33
CLRB cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 13196033.00
CLRB cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -3378.00
CLRB balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1528825.00
CLRB balance_sheet (quarterly, 2026-03-31) — Capital Stock: 520820.00
CLRB balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 8347090.00
CLRB balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 8347090.00
CLRB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -3378.00
CLRB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4845565.00
CLRB cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 0.00
CLRB cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 301278.00
CLRB cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 245498.00
CLRB cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 546776.00
CLRB cash_flow (quarterly, 2026-03-31) — Changes In Cash: -4848943.00
CLRB balance_sheet (quarterly, 2026-03-31) — Common Stock: 42.00
CLRB balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2814309.00
CLRB balance_sheet (quarterly, 2026-03-31) — Current Assets: 9267128.00
CLRB balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 0.00
CLRB balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4873826.00
CLRB cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: -110018.00
CLRB cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: -110018.00
CLRB income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 4240129.00
CLRB income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.33
CLRB income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -5653946.00
CLRB income_statement (quarterly, 2026-03-31) — EBIT: -5793942.00
CLRB income_statement (quarterly, 2026-03-31) — EBITDA: -5793942.00
CLRB cash_flow (quarterly, 2026-03-31) — End Cash Position: 8347090.00
CLRB cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -4848943.00
CLRB cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -77000.00
CLRB income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 77000.00
CLRB income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 2786713.00
CLRB balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1822853.00
CLRB income_statement (quarterly, 2026-03-31) — Interest Income: 62996.00
CLRB income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 62996.00
CLRB balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2814309.00
CLRB cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -3378.00
CLRB balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1528825.00
CLRB balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1528825.00
CLRB income_statement (quarterly, 2026-03-31) — Net Income: -5653946.00
CLRB income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -5653946.00
CLRB income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -5653946.00
CLRB income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -5653946.00
CLRB income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -5653946.00
CLRB cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -5653946.00
CLRB income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -5653946.00
CLRB income_statement (quarterly, 2026-03-31) — Net Interest Income: 62996.00
CLRB income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 62996.00
CLRB balance_sheet (quarterly, 2026-03-31) — Net PPE: 1822853.00
CLRB cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -3378.00
CLRB balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 3335087.00
CLRB income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -5870942.00
CLRB income_statement (quarterly, 2026-03-31) — Normalized Income: -5730946.00
CLRB cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -4845565.00
CLRB cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -77000.00
CLRB income_statement (quarterly, 2026-03-31) — Operating Income: -5793942.00
CLRB income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
CLRB balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 4240129.00
CLRB balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 920038.00
CLRB balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 149000.00
CLRB income_statement (quarterly, 2026-03-31) — Other Gand A: 2786713.00
CLRB income_statement (quarterly, 2026-03-31) — Other Income Expense: 77000.00
CLRB cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -3246.00
CLRB balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 29780.00
CLRB balance_sheet (quarterly, 2026-03-31) — Other Properties: 1822853.00
CLRB balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 4724826.00
CLRB balance_sheet (quarterly, 2026-03-31) — Preferred Securities Outside Stock Equity: 1382023.00
CLRB balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 520778.00
CLRB balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 520778.00
CLRB income_statement (quarterly, 2026-03-31) — Pretax Income: -5653946.00
CLRB cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -3378.00
CLRB income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: -110018.00
CLRB income_statement (quarterly, 2026-03-31) — Research And Development: 3007229.00
CLRB balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -274787446.00
CLRB income_statement (quarterly, 2026-03-31) — Selling General And Administration: 2786713.00
CLRB balance_sheet (quarterly, 2026-03-31) — Share Issued: 4240129.00
CLRB cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 451869.00
CLRB balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 3335087.00
CLRB balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2814309.00
CLRB income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CLRB income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
CLRB balance_sheet (quarterly, 2026-03-31) — Total Assets: 11119761.00
CLRB balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 3335087.00
CLRB balance_sheet (quarterly, 2026-03-31) — Total Debt: 1528825.00
CLRB balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 3335087.00
CLRB income_statement (quarterly, 2026-03-31) — Total Expenses: 5793942.00
CLRB balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7784674.00
CLRB balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1852633.00
CLRB balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2910848.00
CLRB income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -5793942.00
CLRB income_statement (quarterly, 2026-03-31) — Total Unusual Items: 77000.00
CLRB income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 77000.00
CLRB balance_sheet (quarterly, 2026-03-31) — Working Capital: 4393302.00
CLRO balance_sheet (annual, 2021-12-31) — Accounts Receivable: 4991000.00
CLRO balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -326000.00
CLRO balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 1220000.00
CLRO cash_flow (annual, 2021-12-31) — Capital Expenditure: -8347000.00
CLRO cash_flow (annual, 2021-12-31) — Capital Expenditure Reported: -7836000.00
CLRO cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -69000.00
CLRO cash_flow (annual, 2021-12-31) — Change In Prepaid Assets: -2485000.00
CLRO cash_flow (annual, 2021-12-31) — Change In Receivables: -163000.00
CLRO cash_flow (annual, 2021-12-31) — Changes In Account Receivables: 203000.00
CLRO cash_flow (annual, 2021-12-31) — Common Stock Issuance: 10000000.00
CLRO balance_sheet (annual, 2021-12-31) — Current Debt: 3481000.00
CLRO balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 54000.00
CLRO balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 54000.00
CLRO balance_sheet (annual, 2021-12-31) — Finished Goods: 5948000.00
CLRO balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 25086000.00
CLRO balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 5317000.00
CLRO income_statement (annual, 2021-12-31) — Interest Expense: 514000.00
CLRO income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 514000.00
CLRO balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 1220000.00
CLRO balance_sheet (annual, 2021-12-31) — Investments And Advances: 1220000.00
CLRO cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 10000000.00
CLRO cash_flow (annual, 2021-12-31) — Issuance Of Debt: 2000000.00
CLRO balance_sheet (annual, 2021-12-31) — Long Term Debt: 1535000.00
CLRO cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
CLRO cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -1098000.00
CLRO cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 10000000.00
CLRO balance_sheet (annual, 2021-12-31) — Net Debt: 3945000.00
CLRO cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -290000.00
CLRO cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -1098000.00
CLRO cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -712000.00
CLRO cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -221000.00
CLRO cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 2000000.00
CLRO balance_sheet (annual, 2021-12-31) — Other Current Assets: 4021000.00
CLRO balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 3481000.00
CLRO balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 25086000.00
CLRO balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 655000.00
CLRO balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 1790000.00
CLRO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 4021000.00
CLRO cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 0.00
CLRO cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -290000.00
CLRO cash_flow (annual, 2021-12-31) — Purchase Of PPE: -221000.00
CLRO balance_sheet (annual, 2021-12-31) — Raw Materials: 4085000.00
CLRO balance_sheet (annual, 2021-12-31) — Receivables: 12526000.00
CLRO cash_flow (annual, 2021-12-31) — Repayment Of Debt: -1098000.00
CLRO income_statement (annual, 2021-12-31) — Research And Development: 5794000.00
CLRO income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 6736000.00
CLRO cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 2000000.00
CLRO balance_sheet (annual, 2021-12-31) — Taxes Receivable: 7535000.00
CLRO income_statement (annual, 2022-12-31) — +Operating Expense: 16679000.00
CLRO income_statement (annual, 2022-12-31) — +Total Revenue: 25205000.00
CLRO balance_sheet (annual, 2022-12-31) — Accounts Payable: 1284000.00
CLRO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3603000.00
CLRO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -991000.00
CLRO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 74910000.00
CLRO balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -326000.00
CLRO income_statement (annual, 2022-12-31) — Basic Average Shares: 1595864.00
CLRO income_statement (annual, 2022-12-31) — Basic EPS: 12.90
CLRO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1071000.00
CLRO cash_flow (annual, 2022-12-31) — Capital Expenditure: -925000.00
CLRO cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -737000.00
CLRO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1133000.00
CLRO balance_sheet (annual, 2022-12-31) — Capital Stock: 24000.00
CLRO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 984000.00
CLRO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 984000.00
CLRO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
CLRO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 2051000.00
CLRO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 2085000.00
CLRO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -4179000.00
CLRO cash_flow (annual, 2022-12-31) — Change In Account Payable: -4104000.00
CLRO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 485000.00
CLRO cash_flow (annual, 2022-12-31) — Change In Inventory: 1812000.00
CLRO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -270000.00
CLRO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 9000.00
CLRO cash_flow (annual, 2022-12-31) — Change In Payable: -4104000.00
CLRO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -3619000.00
CLRO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 684000.00
CLRO cash_flow (annual, 2022-12-31) — Change In Receivables: 7854000.00
CLRO cash_flow (annual, 2022-12-31) — Change In Working Capital: 6470000.00
CLRO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 1388000.00
CLRO cash_flow (annual, 2022-12-31) — Changes In Cash: -43000.00
CLRO balance_sheet (annual, 2022-12-31) — Common Stock: 24000.00
CLRO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
CLRO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 74130000.00
CLRO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CLRO income_statement (annual, 2022-12-31) — Cost Of Revenue: 15748000.00
CLRO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1058000.00
CLRO balance_sheet (annual, 2022-12-31) — Current Assets: 77427000.00
CLRO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 641000.00
CLRO balance_sheet (annual, 2022-12-31) — Current Debt: 3732000.00
CLRO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 4373000.00
CLRO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 63000.00
CLRO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 63000.00
CLRO balance_sheet (annual, 2022-12-31) — Current Liabilities: 8120000.00
CLRO balance_sheet (annual, 2022-12-31) — Current Provisions: 194000.00
CLRO cash_flow (annual, 2022-12-31) — Depreciation: 3567000.00
CLRO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 3567000.00
CLRO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 3567000.00
CLRO income_statement (annual, 2022-12-31) — Diluted Average Shares: 1679276.00
CLRO income_statement (annual, 2022-12-31) — Diluted EPS: 12.45
CLRO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 20556000.00
CLRO income_statement (annual, 2022-12-31) — EBIT: -7222000.00
CLRO income_statement (annual, 2022-12-31) — EBITDA: -3655000.00
CLRO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -44000.00
CLRO cash_flow (annual, 2022-12-31) — End Cash Position: 984000.00
CLRO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 2051000.00
CLRO balance_sheet (annual, 2022-12-31) — Finished Goods: 4462000.00
CLRO cash_flow (annual, 2022-12-31) — Free Cash Flow: -5104000.00
CLRO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -288000.00
CLRO income_statement (annual, 2022-12-31) — General And Administrative Expense: 6772000.00
CLRO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 2071000.00
CLRO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 3929000.00
CLRO balance_sheet (annual, 2022-12-31) — Gross PPE: 2421000.00
CLRO income_statement (annual, 2022-12-31) — Gross Profit: 9457000.00
CLRO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 88000.00
CLRO income_statement (annual, 2022-12-31) — Interest Expense: 420000.00
CLRO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 420000.00
CLRO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 226000.00
CLRO balance_sheet (annual, 2022-12-31) — Inventory: 8961000.00
CLRO balance_sheet (annual, 2022-12-31) — Invested Capital: 77862000.00
CLRO cash_flow (annual, 2022-12-31) — Investing Cash Flow: 2085000.00
CLRO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 0.00
CLRO balance_sheet (annual, 2022-12-31) — Investments And Advances: 0.00
CLRO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CLRO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 2767000.00
CLRO balance_sheet (annual, 2022-12-31) — Leases: 121000.00
CLRO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 492000.00
CLRO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 492000.00
CLRO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 767000.00
CLRO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -720000.00
CLRO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 107000.00
CLRO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CLRO balance_sheet (annual, 2022-12-31) — Net Debt: 2748000.00
CLRO income_statement (annual, 2022-12-31) — Net Income: 20556000.00
CLRO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 20556000.00
CLRO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 20556000.00
CLRO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 20556000.00
CLRO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 20556000.00
CLRO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 20556000.00
CLRO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 20556000.00
CLRO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -137000.00
CLRO income_statement (annual, 2022-12-31) — Net Interest Income: -420000.00
CLRO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 3010000.00
CLRO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 2047000.00
CLRO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 47000.00
CLRO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -420000.00
CLRO balance_sheet (annual, 2022-12-31) — Net PPE: 1430000.00
CLRO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -51000.00
CLRO cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 2000000.00
CLRO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 72059000.00
CLRO income_statement (annual, 2022-12-31) — Normalized EBITDA: -3655000.00
CLRO income_statement (annual, 2022-12-31) — Normalized Income: 20556000.00
CLRO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -4179000.00
CLRO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1382000.00
CLRO income_statement (annual, 2022-12-31) — Operating Income: -7222000.00
CLRO income_statement (annual, 2022-12-31) — Operating Revenue: 25205000.00
CLRO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1597051.00
CLRO balance_sheet (annual, 2022-12-31) — Other Current Assets: 7808000.00
CLRO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 3732000.00
CLRO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -288000.00
CLRO income_statement (annual, 2022-12-31) — Other Gand A: 6772000.00
CLRO income_statement (annual, 2022-12-31) — Other Income Expense: 35102000.00
CLRO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 2071000.00
CLRO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -33503000.00
CLRO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 2822000.00
CLRO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1008000.00
CLRO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 35102000.00
CLRO balance_sheet (annual, 2022-12-31) — Other Properties: 2193000.00
CLRO balance_sheet (annual, 2022-12-31) — Other Receivables: 55000000.00
CLRO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 0.00
CLRO balance_sheet (annual, 2022-12-31) — Payables: 1284000.00
CLRO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 2342000.00
CLRO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1148000.00
CLRO income_statement (annual, 2022-12-31) — Pretax Income: 27460000.00
CLRO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 4000.00
CLRO balance_sheet (annual, 2022-12-31) — Properties: 0.00
CLRO cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -137000.00
CLRO cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
CLRO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -51000.00
CLRO balance_sheet (annual, 2022-12-31) — Raw Materials: 4499000.00
CLRO balance_sheet (annual, 2022-12-31) — Receivables: 59674000.00
CLRO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 15748000.00
CLRO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 3567000.00
CLRO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -720000.00
CLRO income_statement (annual, 2022-12-31) — Research And Development: 4390000.00
CLRO balance_sheet (annual, 2022-12-31) — Retained Earnings: -516000.00
CLRO cash_flow (annual, 2022-12-31) — Sale Of Investment: 3010000.00
CLRO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 5517000.00
CLRO income_statement (annual, 2022-12-31) — Selling General And Administration: 12289000.00
CLRO balance_sheet (annual, 2022-12-31) — Share Issued: 1597051.00
CLRO cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 2000000.00
CLRO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 113000.00
CLRO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 74130000.00
CLRO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 72059000.00
CLRO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CLRO income_statement (annual, 2022-12-31) — Tax Provision: 6904000.00
CLRO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.25
CLRO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1071000.00
CLRO balance_sheet (annual, 2022-12-31) — Total Assets: 83750000.00
CLRO balance_sheet (annual, 2022-12-31) — Total Capitalization: 74130000.00
CLRO balance_sheet (annual, 2022-12-31) — Total Debt: 4865000.00
CLRO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 74130000.00
CLRO income_statement (annual, 2022-12-31) — Total Expenses: 32427000.00
CLRO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 9620000.00
CLRO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 6323000.00
CLRO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1500000.00
CLRO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -7222000.00
CLRO income_statement (annual, 2022-12-31) — Total Other Finance Cost: 420000.00
CLRO balance_sheet (annual, 2022-12-31) — Working Capital: 69307000.00
CLRO income_statement (annual, 2023-12-31) — +Operating Expense: 13129000.00
CLRO income_statement (annual, 2023-12-31) — +Total Revenue: 18704000.00
CLRO balance_sheet (annual, 2023-12-31) — Accounts Payable: 1945000.00
CLRO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 3279000.00
CLRO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1232000.00
CLRO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 46047000.00
CLRO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -326000.00
CLRO balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 916000.00
CLRO income_statement (annual, 2023-12-31) — Basic Average Shares: 1597212.00
CLRO income_statement (annual, 2023-12-31) — Basic EPS: -0.30
CLRO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 984000.00
CLRO cash_flow (annual, 2023-12-31) — Capital Expenditure: -510000.00
CLRO cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: 0.00
CLRO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1048000.00
CLRO balance_sheet (annual, 2023-12-31) — Capital Stock: 24000.00
CLRO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 17835000.00
CLRO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 21315000.00
CLRO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -28979000.00
CLRO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -32892000.00
CLRO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -4883000.00
CLRO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 54628000.00
CLRO cash_flow (annual, 2023-12-31) — Change In Account Payable: 661000.00
CLRO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -497000.00
CLRO cash_flow (annual, 2023-12-31) — Change In Inventory: -2381000.00
CLRO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -354000.00
CLRO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -33000.00
CLRO cash_flow (annual, 2023-12-31) — Change In Payable: 661000.00
CLRO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 164000.00
CLRO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 3752000.00
CLRO cash_flow (annual, 2023-12-31) — Change In Receivables: 56359000.00
CLRO cash_flow (annual, 2023-12-31) — Change In Working Capital: 57507000.00
CLRO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 324000.00
CLRO cash_flow (annual, 2023-12-31) — Changes In Cash: 16853000.00
CLRO balance_sheet (annual, 2023-12-31) — Common Stock: 24000.00
CLRO cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -28979000.00
CLRO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 44685000.00
CLRO income_statement (annual, 2023-12-31) — Cost Of Revenue: 12347000.00
CLRO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1081000.00
CLRO balance_sheet (annual, 2023-12-31) — Current Assets: 43317000.00
CLRO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 383000.00
CLRO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 383000.00
CLRO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 30000.00
CLRO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 30000.00
CLRO balance_sheet (annual, 2023-12-31) — Current Liabilities: 4265000.00
CLRO balance_sheet (annual, 2023-12-31) — Current Provisions: 194000.00
CLRO cash_flow (annual, 2023-12-31) — Depreciation: 1338000.00
CLRO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1338000.00
CLRO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1338000.00
CLRO income_statement (annual, 2023-12-31) — Diluted Average Shares: 1597212.00
CLRO income_statement (annual, 2023-12-31) — Diluted EPS: -0.30
CLRO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -560000.00
CLRO income_statement (annual, 2023-12-31) — EBIT: -6772000.00
CLRO income_statement (annual, 2023-12-31) — EBITDA: -5434000.00
CLRO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -2000.00
CLRO cash_flow (annual, 2023-12-31) — End Cash Position: 17835000.00
CLRO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -32892000.00
CLRO balance_sheet (annual, 2023-12-31) — Finished Goods: 8539000.00
CLRO cash_flow (annual, 2023-12-31) — Free Cash Flow: 54118000.00
CLRO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -4000000.00
CLRO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -310000.00
CLRO income_statement (annual, 2023-12-31) — General And Administrative Expense: 4561000.00
CLRO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1689000.00
CLRO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 3605000.00
CLRO balance_sheet (annual, 2023-12-31) — Gross PPE: 2752000.00
CLRO income_statement (annual, 2023-12-31) — Gross Profit: 6357000.00
CLRO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 6905000.00
CLRO income_statement (annual, 2023-12-31) — Interest Expense: 537000.00
CLRO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 537000.00
CLRO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 343000.00
CLRO balance_sheet (annual, 2023-12-31) — Inventory: 10625000.00
CLRO balance_sheet (annual, 2023-12-31) — Invested Capital: 44685000.00
CLRO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -4883000.00
CLRO balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 916000.00
CLRO balance_sheet (annual, 2023-12-31) — Investments And Advances: 916000.00
CLRO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
CLRO balance_sheet (annual, 2023-12-31) — Leases: 193000.00
CLRO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 665000.00
CLRO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 665000.00
CLRO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
CLRO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -3920000.00
CLRO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 127000.00
CLRO income_statement (annual, 2023-12-31) — Net Income: -560000.00
CLRO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -560000.00
CLRO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -560000.00
CLRO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -560000.00
CLRO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -560000.00
CLRO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -560000.00
CLRO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -560000.00
CLRO cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -135000.00
CLRO income_statement (annual, 2023-12-31) — Net Interest Income: -537000.00
CLRO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -4373000.00
CLRO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -3920000.00
CLRO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -3920000.00
CLRO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -537000.00
CLRO balance_sheet (annual, 2023-12-31) — Net PPE: 1520000.00
CLRO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -375000.00
CLRO cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
CLRO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 42996000.00
CLRO income_statement (annual, 2023-12-31) — Normalized EBITDA: -5434000.00
CLRO income_statement (annual, 2023-12-31) — Normalized Income: -560000.00
CLRO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 54628000.00
CLRO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -4047000.00
CLRO income_statement (annual, 2023-12-31) — Operating Income: -6772000.00
CLRO income_statement (annual, 2023-12-31) — Operating Revenue: 18704000.00
CLRO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1597943.00
CLRO balance_sheet (annual, 2023-12-31) — Other Current Assets: 4062000.00
CLRO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -310000.00
CLRO income_statement (annual, 2023-12-31) — Other Gand A: 4561000.00
CLRO income_statement (annual, 2023-12-31) — Other Income Expense: 7183000.00
CLRO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 1689000.00
CLRO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 281000.00
CLRO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 3252000.00
CLRO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1079000.00
CLRO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 7183000.00
CLRO balance_sheet (annual, 2023-12-31) — Other Properties: 2432000.00
CLRO balance_sheet (annual, 2023-12-31) — Other Receivables: 4000000.00
CLRO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 3480000.00
CLRO balance_sheet (annual, 2023-12-31) — Payables: 1945000.00
CLRO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 3026000.00
CLRO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 632000.00
CLRO income_statement (annual, 2023-12-31) — Pretax Income: -126000.00
CLRO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 7000.00
CLRO balance_sheet (annual, 2023-12-31) — Properties: 0.00
CLRO cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 0.00
CLRO cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -135000.00
CLRO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -10298000.00
CLRO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -375000.00
CLRO balance_sheet (annual, 2023-12-31) — Raw Materials: 2086000.00
CLRO balance_sheet (annual, 2023-12-31) — Receivables: 7315000.00
CLRO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 12347000.00
CLRO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1338000.00
CLRO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -3920000.00
CLRO income_statement (annual, 2023-12-31) — Research And Development: 3671000.00
CLRO balance_sheet (annual, 2023-12-31) — Retained Earnings: -1076000.00
CLRO cash_flow (annual, 2023-12-31) — Sale Of Investment: 5925000.00
CLRO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 4897000.00
CLRO income_statement (annual, 2023-12-31) — Selling General And Administration: 9458000.00
CLRO balance_sheet (annual, 2023-12-31) — Share Issued: 1597943.00
CLRO cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
CLRO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 109000.00
CLRO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 44685000.00
CLRO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 42996000.00
CLRO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CLRO income_statement (annual, 2023-12-31) — Tax Provision: 434000.00
CLRO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
CLRO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 36000.00
CLRO balance_sheet (annual, 2023-12-31) — Total Assets: 50694000.00
CLRO balance_sheet (annual, 2023-12-31) — Total Capitalization: 44685000.00
CLRO balance_sheet (annual, 2023-12-31) — Total Debt: 1048000.00
CLRO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 44685000.00
CLRO income_statement (annual, 2023-12-31) — Total Expenses: 25476000.00
CLRO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 6009000.00
CLRO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 7377000.00
CLRO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1744000.00
CLRO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -6772000.00
CLRO income_statement (annual, 2023-12-31) — Total Other Finance Cost: 537000.00
CLRO balance_sheet (annual, 2023-12-31) — Working Capital: 39052000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1868000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Allowance For Doubtful Accounts Receivable: -325000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 222000.00
CLRO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 1599534.00
CLRO income_statement (quarterly, 2024-09-30) — Basic EPS: -1.29
CLRO cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -55000.00
CLRO cash_flow (quarterly, 2024-09-30) — Cash Dividends Paid: -6000.00
CLRO cash_flow (quarterly, 2024-09-30) — Change In Inventory: 54000.00
CLRO cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: -1000.00
CLRO cash_flow (quarterly, 2024-09-30) — Change In Prepaid Assets: -166000.00
CLRO cash_flow (quarterly, 2024-09-30) — Change In Receivables: 707000.00
CLRO cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: 707000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Current Deferred Liabilities: 22000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Current Deferred Revenue: 22000.00
CLRO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 1599534.00
CLRO income_statement (quarterly, 2024-09-30) — Diluted EPS: -1.29
CLRO cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: -31000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 1567000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Gross Accounts Receivable: 2193000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 222000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 222000.00
CLRO cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
CLRO cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
CLRO income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: -1346000.00
CLRO cash_flow (quarterly, 2024-09-30) — Net Intangibles Purchase And Sale: -35000.00
CLRO cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
CLRO cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
CLRO cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: -20000.00
CLRO cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: 0.00
CLRO cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: -31000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 4054000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 1567000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 1079000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1136000.00
CLRO cash_flow (quarterly, 2024-09-30) — Purchase Of Intangibles: -35000.00
CLRO cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -20000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Raw Materials: 1316000.00
CLRO balance_sheet (quarterly, 2024-09-30) — Receivables: 1895000.00
CLRO cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
CLRO cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
CLRO cash_flow (quarterly, 2024-09-30) — Short Term Debt Issuance: 0.00
CLRO balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 27000.00
CLRO income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: -29000.00
CLRO income_statement (annual, 2024-12-31) — +Operating Expense: 1941000.00
CLRO income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
CLRO balance_sheet (annual, 2024-12-31) — Accounts Payable: 76000.00
CLRO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 2208000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 2208000.00
CLRO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: 0.00
CLRO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: 0.00
CLRO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 31694000.00
CLRO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -405000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -405000.00
CLRO balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 16944000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 16944000.00
CLRO income_statement (annual, 2024-12-31) — Basic Average Shares: 1598756.00
CLRO income_statement (annual, 2024-12-31) — Basic EPS: -5.61
CLRO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 17835000.00
CLRO cash_flow (annual, 2024-12-31) — Capital Expenditure: -306000.00
CLRO cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -63000.00
CLRO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 771000.00
CLRO balance_sheet (annual, 2024-12-31) — Capital Stock: 2000.00
CLRO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1417000.00
CLRO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1417000.00
CLRO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -14496000.00
CLRO cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: 0.00
CLRO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -14473000.00
CLRO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 4495000.00
CLRO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -8919000.00
CLRO cash_flow (annual, 2024-12-31) — Cash Flow From Discontinued Operation: 2497000.00
CLRO cash_flow (annual, 2024-12-31) — Change In Account Payable: 44000.00
CLRO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -41000.00
CLRO cash_flow (annual, 2024-12-31) — Change In Inventory: 0.00
CLRO cash_flow (quarterly, 2024-12-31) — Change In Inventory: -809000.00
CLRO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -277000.00
CLRO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -13000.00
CLRO cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: -5000.00
CLRO cash_flow (annual, 2024-12-31) — Change In Payable: 44000.00
CLRO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 3000.00
CLRO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 192000.00
CLRO cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 152000.00
CLRO cash_flow (annual, 2024-12-31) — Change In Receivables: 5018000.00
CLRO cash_flow (quarterly, 2024-12-31) — Change In Receivables: -403000.00
CLRO cash_flow (annual, 2024-12-31) — Change In Working Capital: -274000.00
CLRO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 4992000.00
CLRO cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -420000.00
CLRO cash_flow (annual, 2024-12-31) — Changes In Cash: -16400000.00
CLRO balance_sheet (annual, 2024-12-31) — Common Stock: 2000.00
CLRO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -14496000.00
CLRO cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: 0.00
CLRO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 21331000.00
CLRO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
CLRO income_statement (annual, 2024-12-31) — Cost Of Revenue: 194000.00
CLRO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 136000.00
CLRO balance_sheet (annual, 2024-12-31) — Current Assets: 18753000.00
CLRO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 257000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 257000.00
CLRO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 257000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 257000.00
CLRO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 17000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 17000.00
CLRO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 17000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 17000.00
CLRO balance_sheet (annual, 2024-12-31) — Current Liabilities: 3545000.00
CLRO balance_sheet (annual, 2024-12-31) — Current Provisions: 194000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Current Provisions: 194000.00
CLRO cash_flow (annual, 2024-12-31) — Depreciation: 240000.00
CLRO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 240000.00
CLRO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 240000.00
CLRO income_statement (annual, 2024-12-31) — Diluted Average Shares: 1598756.00
CLRO income_statement (annual, 2024-12-31) — Diluted EPS: -5.61
CLRO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -8983000.00
CLRO income_statement (annual, 2024-12-31) — EBIT: -2135000.00
CLRO income_statement (annual, 2024-12-31) — EBITDA: -1895000.00
CLRO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -18000.00
CLRO cash_flow (annual, 2024-12-31) — End Cash Position: 1417000.00